233 related articles for article (PubMed ID: 24517184)
1. Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements.
Trossaert M; Lienhart A; Nougier C; Fretigny M; Sigaud M; Meunier S; Fouassier M; Ternisien C; Negrier C; Dargaud Y
Haemophilia; 2014 Jul; 20(4):550-8. PubMed ID: 24517184
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of three automated chromogenic FVIII kits for the diagnosis of mild discrepant haemophilia A.
Rodgers SE; Duncan EM; Sobieraj-Teague M; Lloyd JV
Int J Lab Hematol; 2009 Apr; 31(2):180-8. PubMed ID: 18190586
[TBL] [Abstract][Full Text] [Related]
3. Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy.
Gilmore R; Harmon S; Gannon C; Byrne M; O'Donnell JS; Jenkins PV
Haemophilia; 2010 Jul; 16(4):671-4. PubMed ID: 20148980
[TBL] [Abstract][Full Text] [Related]
4. Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays.
Pavlova A; Delev D; Pezeshkpoor B; Müller J; Oldenburg J
Thromb Haemost; 2014 May; 111(5):851-61. PubMed ID: 24452774
[TBL] [Abstract][Full Text] [Related]
5. One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype.
Cid AR; Calabuig M; Cortina V; Casaña P; Haya S; Moret A; Cabrera N; Aznar JA
Haemophilia; 2008 Sep; 14(5):1049-54. PubMed ID: 18540892
[TBL] [Abstract][Full Text] [Related]
6. The one-stage assay or chromogenic assay to monitor baseline factor VIII levels and desmopressin effect in non-severe haemophilia A: Superiority or non-inferiority?
Schütte LM; Hodes LS; van Moort I; Stoof SCM; Leebeek FWG; Cnossen MH; de Maat MPM; Kruip MJHA
Haemophilia; 2020 Sep; 26(5):916-922. PubMed ID: 32713129
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic testing for mild hemophilia a in patients with discrepant one-stage, two-stage, and chromogenic factor VIII:C assays.
Duncan EM; Rodgers SE; McRae SJ
Semin Thromb Hemost; 2013 Apr; 39(3):272-82. PubMed ID: 23460037
[TBL] [Abstract][Full Text] [Related]
8. Variation in baseline factor VIII concentration in a retrospective cohort of mild/moderate hemophilia A patients carrying identical F8 mutations.
Loomans JI; van Velzen AS; Eckhardt CL; Peters M; Mäkipernaa A; Holmstrom M; Brons PP; Dors N; Haya S; Voorberg J; van der Bom JG; Fijnvandraat K
J Thromb Haemost; 2017 Feb; 15(2):246-254. PubMed ID: 27943580
[TBL] [Abstract][Full Text] [Related]
9. Assay discrepancy in mild haemophilia A.
Armstrong E; Hillarp A
Eur J Haematol Suppl; 2014 Aug; 76():48-50. PubMed ID: 24957107
[TBL] [Abstract][Full Text] [Related]
10. Tyr346-->Cys mutation results in factor VIII:C assay discrepancy and a normal bleeding phenotype - is this mild haemophilia A?
Lyall H; Hill M; Westby J; Grimley C; Dolan G
Haemophilia; 2008 Jan; 14(1):78-80. PubMed ID: 18034822
[TBL] [Abstract][Full Text] [Related]
11. One-stage vs. chromogenic assays in haemophilia A.
Potgieter JJ; Damgaard M; Hillarp A
Eur J Haematol; 2015 Feb; 94 Suppl 77():38-44. PubMed ID: 25560793
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A.
Gu JM; Ramsey P; Evans V; Tang L; Apeler H; Leong L; Murphy JE; Laux V; Myles T
Haemophilia; 2014 Jul; 20(4):593-600. PubMed ID: 24471985
[TBL] [Abstract][Full Text] [Related]
13. Individual thrombin generation and spontaneous bleeding rate during personalized prophylaxis with Nuwiq
Dargaud Y; Negrier C; Rusen L; Windyga J; Georgiev P; Bichler J; Solomon C; Knaub S; Lissitchkov T; Klamroth R
Haemophilia; 2018 Jul; 24(4):619-627. PubMed ID: 29855112
[TBL] [Abstract][Full Text] [Related]
14. Discrepancy between the results of one-stage and chromogenic factor VIII: C assays in patients with mild/moderate hemophilia A.
Vosough F; Ahmadinejad M; Toogeh G; Karimi K; Homayoun S; Managhchi MR; Arabkhazaeli A
Blood Coagul Fibrinolysis; 2020 Dec; 31(8):530-535. PubMed ID: 33141777
[TBL] [Abstract][Full Text] [Related]
15. Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?
Salvagno GL; Astermark J; Lippi G; Ekman M; Franchini M; Guidi GC; Berntorp E
Haemophilia; 2009 Jan; 15(1):290-6. PubMed ID: 19149855
[TBL] [Abstract][Full Text] [Related]
16. In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay results.
Rodgers SE; Duncan EM; Barbulescu DM; Quinn DM; Lloyd JV
Br J Haematol; 2007 Jan; 136(1):138-45. PubMed ID: 17222201
[TBL] [Abstract][Full Text] [Related]
17. Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.
Luna-Záizar H; Beltrán-Miranda CP; Esparza-Flores MA; Soto-Padilla J; Bergés-García A; Rodríguez-Zepeda MD; Pompa-Garza MT; Jaloma-Cruz AR
Haemophilia; 2014 Jan; 20(1):e7-14. PubMed ID: 24354488
[TBL] [Abstract][Full Text] [Related]
18. p.Tyr365Cys change in factor VIII: haemophilia A, but not as we know it.
Bowyer AE; Goodeve A; Liesner R; Mumford AD; Kitchen S; Makris M
Br J Haematol; 2011 Sep; 154(5):618-25. PubMed ID: 21751985
[TBL] [Abstract][Full Text] [Related]
19. New quantitative aPTT waveform analysis and its application in laboratory management of haemophilia A patients.
Milos M; Coen Herak D; Zupancic-Salek S; Zadro R
Haemophilia; 2014 Nov; 20(6):898-904. PubMed ID: 25273337
[TBL] [Abstract][Full Text] [Related]
20. Association between phenotype and genotype in carriers of haemophilia A.
Miesbach W; Alesci S; Geisen C; Oldenburg J
Haemophilia; 2011 Mar; 17(2):246-51. PubMed ID: 21118332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
